CARTESIAN THERAPEUTICS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 36.76 USD | +2.11% |
|
+28.22% | +75.20% |
| 12:52pm | Oppenheimer Initiates Cartesian Therapeutics With Outperform Rating, $50 Price Target | MT |
| May. 24 | Mizuho Securities Starts Cartesian Therapeutics With Buy Rating | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Neutral |
| Resistance | 32.25 | 40.50 | 39.90 |
| Spread/Res. | +12.36% | -10.53% | -9.19% |
| Spread/Supp. | +47.48% | +176.18% | +172.24% |
| Support | 24.57 | 13.12 | 13.31 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- RNAC Stock
- Charts Cartesian Therapeutics, Inc.
